| Feb 11 2015 |
Biosimilars Update re: Biologics Price Competition and Innovation Act |
Proskauer Rose LLP |
| Feb 11 2015 |
House To Consider Keystone, Tax Extenders; Senate To Vote On Director Of National Drug Control Policy |
Squire Patton Boggs (US) LLP |
| Feb 11 2015 |
Senate Takes Shot At Vaccine-Preventable Diseases; Health Cybersecurity Examined; GAO Reports On ICD-10 |
Squire Patton Boggs (US) LLP |
| Feb 11 2015 |
FTC Tastes “Sweet” Victory: The Implications of POM Wonderful for Government Practice |
Mintz |
| Feb 10 2015 |
Clinical Trial Data: Shared Resource or Private Property? |
Faegre Drinker |
| Feb 10 2015 |
Important Developments in FDA Regulation of Software, Including Mobile Apps |
Covington & Burling LLP |
| Feb 10 2015 |
Exploring Indian Country Marijuana |
Godfrey & Kahn S.C. |
| Feb 10 2015 |
Seventh Circuit Says Assignment Law Not a Basis for FCA Suit (False Claims Act Suit) |
McDermott Will & Emery |
| Feb 10 2015 |
China Struggles With Food Safety |
Covington & Burling LLP |
| Feb 9 2015 |
Out-of-Market Divestiture Required to Resolve Competitive Concerns |
McDermott Will & Emery |
| Feb 9 2015 |
FDA Issues Draft Guidance on Combination Product Manufacturing |
Covington & Burling LLP |
| Feb 9 2015 |
Alcohol & Tobacco Tax & Trade Bureau (TTB) Publishes Semi-Annual Regulatory Agenda with Plans and Goals for the Coming Year |
McDermott Will & Emery |
| Feb 7 2015 |
21st Century Cures Discussion Draft Act Proposes Changes to Medical Device Regulation |
Covington & Burling LLP |
| Feb 6 2015 |
Testosterone Replacement Clinic Agrees to Pay the Government $1.6 Million for Alleged Medicaid Fraud |
Tycko & Zavareei LLP |
| Feb 6 2015 |
FDA Issues Draft Guidances Aimed at Reducing Oversight of Low Risk General Wellness Products and Medical Device Accessories |
Greenberg Traurig, LLP |
| Feb 6 2015 |
Nice Insight on Trends and Expectations for Outsourcing in the Biopharmaceutical Industry |
Morgan, Lewis & Bockius LLP |
| Feb 6 2015 |
Mixing Things Up: Let’s Talk Recipes, Part One of a Four-Part Series on Copyright |
Lewis Roca Rothgerber LLP |
| Feb 6 2015 |
Is Compulsory Licensing of Generic Medicines Coming to the Russian Federation? |
Michael Best & Friedrich LLP |
| Feb 5 2015 |
Consider Non-Regulatory Alternatives, Small Business Panel on Infectious Diseases Tells OSHA |
Jackson Lewis P.C. |
| Feb 5 2015 |
FDA Requests Comments on WHO Recommendation to Classify Two Common Industrial Solvents as Psychotropic Substances |
Beveridge & Diamond PC |
| Feb 5 2015 |
New Rule on Medicare Reimbursement for Chronic Care Management Services |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Feb 5 2015 |
President’s Budget Includes Funding for Precision Medicine Initiative |
Covington & Burling LLP |
| Feb 4 2015 |
FDA Issues Draft Guidance on General Wellness Devices and on Medical Device Accessories |
McDermott Will & Emery |
| Feb 4 2015 |
New York Targets Popular Supplements: Whistleblower |
Mahany Law |
| Feb 3 2015 |
Filthy Pharma – Whistleblowers and Current Good Manufacturing Practices |
Mahany Law |
| Feb 3 2015 |
Are Lower Cost Drugs Less Effective? It May Depend on the Patient’s Perspective. |
Epstein Becker & Green, P.C. |
| Feb 2 2015 |
FDA Issues Draft Guidance on Medical Device Accessories |
Barnes & Thornburg LLP |
| Feb 2 2015 |
EMA Transparency Policy – EMA Launches Public Consultation On The Publication Of Information Under The New EU Clinical Trials Regulation |
Covington & Burling LLP |
| Jan 30 2015 |
Federal Circuit Upholds PTO Refusal to Withdraw Unauthorized Terminal Disclaimer |
McDermott Will & Emery |
| Jan 30 2015 |
Practice Considerations Post Teva v. Sandoz |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Jan 30 2015 |
No Declaratory Jurisdiction Without Biosimilarity Application on File with FDA |
McDermott Will & Emery |
| Jan 30 2015 |
Inherency Requires Factual Evidence that a Limitation Is Necessarily Present or Is the Natural Result |
McDermott Will & Emery |
| Jan 30 2015 |
Court Greenlights “Usual and Customary” Medicare Fraud Case |
Mahany Law |
| Jan 30 2015 |
Statute Intended to Close Deepsouth Loophole Given Broad Interpretation: Promega Corp. v. Life Techs. Corp. |
McDermott Will & Emery |
| Jan 30 2015 |
Even Further Down the Rabbit Hole: New EU Legislation Adds to GMO Quagmire |
Mintz |
